OBJECTIVE: Between July 1988 and July 1998, we performed 433 lung transplants. Forty-five patients had idiopathic pulmonary fibrosis, and operations for these patients included 32 single lung transplants and 13 bilateral sequential lung transplants. This study reviews this experience and compares single lung transplantation and bilateral lung transplantation for pulmonary fibrosis. METHODS: We performed a retrospective review, including inpatient hospital charts, outpatient clinic records, and telephone contact with patients to verify current health status. RESULTS: Perioperative mortality was 4 (8.9%) patients. One patient underwent redo bilateral lung transplantation for reperfusion injury and graft failure after single lung transplantation. The median hospitalization was 22 days. Actuarial survival at 1 and 5 years was 75.5% and 53.5%, respectively, which was not significantly different from our survival for all recipients (85.5% and 56.4%, respectively). Seventeen (41%) of 41 operative survivors have died. Late causes of death included obliterative bronchiolitis with respiratory failure (9), malignancy (3), and cytomegalovirus pneumonitis (2). Hospital mortality was 3 (9.4%) of 32 after single lung transplantation and 1 (7.7%) of 13 after bilateral lung transplantation. There was no difference between single and bilateral lung transplantation with regard to hospital stay. Four (12.5%) of the 32 patients undergoing single lung transplantation required tracheostomy, whereas 3 (23%) of 13 recipients undergoing bilateral lung transplantation required tracheostomy. CONCLUSION: Single or bilateral lung transplantations offer viable therapy for patients with pulmonary fibrosis. We demonstrate no benefit of bilateral over single lung transplantation for patients with this diagnosis. Survival after transplantation appears better than that of historic control subjects receiving standard medical care at other institutions.
OBJECTIVE: Between July 1988 and July 1998, we performed 433 lung transplants. Forty-five patients had idiopathic pulmonary fibrosis, and operations for these patients included 32 single lung transplants and 13 bilateral sequential lung transplants. This study reviews this experience and compares single lung transplantation and bilateral lung transplantation for pulmonary fibrosis. METHODS: We performed a retrospective review, including inpatient hospital charts, outpatient clinic records, and telephone contact with patients to verify current health status. RESULTS: Perioperative mortality was 4 (8.9%) patients. One patient underwent redo bilateral lung transplantation for reperfusion injury and graft failure after single lung transplantation. The median hospitalization was 22 days. Actuarial survival at 1 and 5 years was 75.5% and 53.5%, respectively, which was not significantly different from our survival for all recipients (85.5% and 56.4%, respectively). Seventeen (41%) of 41 operative survivors have died. Late causes of death included obliterative bronchiolitis with respiratory failure (9), malignancy (3), and cytomegalovirus pneumonitis (2). Hospital mortality was 3 (9.4%) of 32 after single lung transplantation and 1 (7.7%) of 13 after bilateral lung transplantation. There was no difference between single and bilateral lung transplantation with regard to hospital stay. Four (12.5%) of the 32 patients undergoing single lung transplantation required tracheostomy, whereas 3 (23%) of 13 recipients undergoing bilateral lung transplantation required tracheostomy. CONCLUSION: Single or bilateral lung transplantations offer viable therapy for patients with pulmonary fibrosis. We demonstrate no benefit of bilateral over single lung transplantation for patients with this diagnosis. Survival after transplantation appears better than that of historic control subjects receiving standard medical care at other institutions.
Authors: Christine L Lau; David M Hoganson; Bryan F Meyers; Ralph J Damiano; G Alexander Patterson Journal: Ann Thorac Surg Date: 2006-04 Impact factor: 4.330
Authors: M G Hartwig; A M Ganapathi; A A Osho; S A Hirji; B R Englum; P J Speicher; S M Palmer; R D Davis; L D Snyder Journal: Am J Transplant Date: 2016-07-15 Impact factor: 8.086
Authors: Denis M Gilmore; Eric L Grogan; Irene D Feurer; Haley Hoy; Scott A Rega; Jean Barnes; Regina Park; Megan Staykov; Michael Via; Ciara M Shaver; C Wright Pinson; Eric S Lambright Journal: Ann Thorac Surg Date: 2018-08-16 Impact factor: 4.330
Authors: Brian C Gulack; Asvin M Ganapathi; Paul J Speicher; James M Meza; Sameer A Hirji; Laurie D Snyder; R Duane Davis; Matthew G Hartwig Journal: Ann Thorac Surg Date: 2015-07-23 Impact factor: 4.330
Authors: Liesbeth ten Klooster; George D Nossent; Johanna M Kwakkel-van Erp; Diana A van Kessel; Erik J Oudijk; Ed A van de Graaf; Bart Luijk; Rogier A Hoek; Bernt van den Blink; Peter Th van Hal; Erik A Verschuuren; Wim van der Bij; Coline H van Moorsel; Jan C Grutters Journal: Lung Date: 2015-09-24 Impact factor: 2.584
Authors: Domenico Calcaterra; Mohammad Bashir; John Keech; Michael J Bates; Joseph W Turek; Kalpaj R Parekh Journal: Ann Thorac Surg Date: 2014-10 Impact factor: 4.330